Dysregulation of the hypothalamic-pituitary-gonadal axis in experimental autoimmune encephalomyelitis and multiple sclerosis

Journal of Neuroimmunology

Volumn 140, Issue 1-2, 2003, Pages 78-87

  Foster, Scott C ^a   Daniels, Crystal ^a   Bourdette, Dennis N ^a,b,c   Bebo Jr , Bruce F ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c PORTLAND VA MEDICAL CENTER   (United States)

Author keywords

Cytokines; Experimental autoimmune encephalomyelitis; Hypothalamic pituitary gonadal axis; Multiple sclerosis; Testosterone

Indexed keywords

CYTOKINE; ESTROGEN; LUTEINIZING HORMONE; TESTOSTERONE;

ADULT; ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; ESTROGEN BLOOD LEVEL; FEMALE; HORMONAL REGULATION; HORMONE INHIBITION; HUMAN; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; INFLAMMATION; LEYDIG CELL; LUTEINIZING HORMONE BLOOD LEVEL; MALE; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SEX DIFFERENCE; SEX HORMONE DETERMINATION; SEXUAL DYSFUNCTION; TESTOSTERONE BLOOD LEVEL; TESTOSTERONE SYNTHESIS;

EID: 0038643772     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(03)00177-2     Document Type: Article

References (48)

1. Bebo B.F. Jr., Vandenbark A.A., Offner H. Male SJL mice do not relapse after induction of EAE with PLP 139-151. J. Neurosci. Res. 45:1996;680-689.
2. Bebo B.F. Jr., Zelinka-Vincent E., Vandenbark A.A., Offner H. Gonadal hormones influence the immune response to PLP 139-151 and the clinical course of relapsing experimental autoimmune encephalomyelitis. J. Neuroimmunol. 84(2):1997;122-130.
3. Bebo B.F. Jr., Schuster J.C., Vandenbark A.A., Offner H. Androgen alters the cytokine profile and reduces encephalitogenicity of myelin reactive T cells. J. Immunol. 162:1999;35-40.
4. Bebo B.F. Jr., Fyfe-Johnson A., Adlard K., Beam A.G., Vandenbark A.A., Offner H. Low dose estrogen therapy ameliorates experimental autoimmune encephalomyelitis in two different inbred mouse strains. J. Immunol. 166:2001;2080-2089.
5. Beeson P.B. Age and sex associations of 40 autoimmune diseases. Am. J. Med. 96:1994;457-463.
6. Choy E.H., Panayi G.S. Cytokine pathways and joint inflammation in rheumatoid arthritis. New Engl. J. Med. 344(12):2001;907-916.
7. Clemens J.W., Bruot B.C. Testicular dysfunction in the adjuvant-induced arthritic rat. J. Androl. 10:1989;419-424.
8. Cutolo M., Balleari E., Giusti M., Monachesi M., Accardo S. Sex hormone status of male patients with rheumatoid arthritis: evidence of low serum concentrations of testosterone at baseline and after human chorionic gonadotropin stimulation. Arthritis Rheum. 31(10):1988;1314-1317.
9. Cutolo M., Sulli A., Villagio B., Seriolo B., Accardo S. Relationships between steroid hormones and cytokines in rheumatoid arthritis and systemic lupus erythematosis. Ann. Rheum. Dis. 57:1998;573-578.
10. Dalal M., Sookhyun K., Voskuhl R.R. Testosterone therapy ameliorates experimental autoimmune encephalomyelitis and induces a T helper bias in the autoantigen-specific T lymphocyte response. J. Immunol. 159:1997;3-6.
11. Duquette P., Pleiner J., Girard M., Charest L., Senecal-Quevillion M., Masse C. The increased susceptibility of women to multiple sclerosis. Can. J. Neurol. Sci. 19:1992;466-476.
12. Ellinwood W.E., Resko J.A. Sex differences in biologically active and immunoreactive gonadotropins in the fetal circulation of rhesus monkeys. Endocrinology. 107:1980;902-907.
13. Foster H.L., Small J.D., Fox J.G. Normative Biology, Immunology and Husbandry of Laboratory Rodents. 1983;99-113 Academic Press, Orlando, FL.
14. Glass A.R., Swerdloff R.S., Bray G., Dahms W.T., Atkinson T. Low serum testosterone and sex hormone binding globulin in massively obese men. J. Clin. Endocrinol. Metab. 45:1977;1211-1219.
15. Griffin A.C., Whitacre C.C. Sex and strain differences in the circadian rhythm fluctuation of endocrine and immune function in the rat: implications for rodent models of autoimmune disease. J. Neuroimmunol. 35:1991;53-64.
16. Hales D.B. The Leydig Cell. 1996;451-466 Cache River Press, Vienna, IL.
17. Hales D.B., Diemer T., Hales K.H. Role of cytokines in testicular function. Endocrine. 10(3):1999;201-217.
18. Ito A., Bebo B.F. Jr., Matejuk A., Zamora A., Silverman M., Fyfe-Johnson A., Offner H. Estrogen treatment down-regulates TNF-α production and reduces the severity of EAE in cytokine knockout mice. J. Immunol. 167:2001;542-552.
19. Kanik K.S., Chrousos G.P., Schumacher H.R., Crane M.L., Yarboro C.H., Wilder R.L. Adrenocorticotropin, glucocorticoid, and androgen secretion in patients with new onset synovitis/rheumatoid arthritis: relations with indices of inflammation. J. Clin. Endocrinol. Metab. 85:2000;1461-1466.
20. Kanzaki M., Morris P.L. Identification and regulation of testicular Interferon-γ receptor subunits: IFN-γ enhances interferon regulatory factor-1 and interleukin-1β converting enzyme expression. Endocrinology. 139(5):1998;2636-2644.
21. Kim S., Voskuhl R.R. Decreased IL-12 production underlies the decreased ability of male lymph node cells to induce experimental autoimmune encephalomyelitis. J. Immunol. 162:1999;5561-5568.
22. Kim S., Liva S.M., Dalal M.A., Verity M.A., Voskuhl R.R. Estriol ameliorates autoimmune demyelinating disease. Implications for multiple sclerosis. Neurology. 52:1999;1230-1238.
23. Kuchroo V.K., Martin C.A., Greer J.M., Ju S.T., Sobel R.A., Dorf M.A. Cytokines and adhesion molecules contribute to the ability of myelin proteolipid protein-specific T cell clones to mediate experimental allergic encephalomyelitis. J. Immunol. 151:1993;4371-4382.
24. Lephart E.D., Baxter C.R., Parker C.R. Jr. Effect of burn trauma on adrenal and testicular steroid hormone production. J. Clin. Endocrinol. Metab. 64(4):1987;842-848.
25. Lilius H.G., Valtonen E.J., Wikstrom J. Sexual problems in patients suffering from multiple sclerosis. J. Chronic Dis. 29:1976;643-647.
26. Liva S.M., Voskuhl R.R. Testosterone acts directly on CD4+ T lymphocytes to increase IL-10 production. J. Immunol. 167(4):2001;2060-2067.
27. Maudit C., Hartmann D.J., Chauvin M.A., Revol A., Morera A.M., Benahmed M. Tumor necrosis factor α inhibits gonadotropin action in cultured porcine Leydig cells: sites of action. Endocrinology. 129:1991;2933-2940.
28. Mealy K., Robinson B., Millette C.F., Majzoub J., Wilmore D.W. The testicular effects of tumor necrosis factor. Ann. Surg. 211:1990;470-475.
29. Offner H., Adlard K., Zamora A., Vandenbark A.A. Estrogen potentiates treatment with TCR protein of female mice with experimental autoimmune encephalomyelitis. J. Clin. Invest. 105(10):2000;1465-1472.
30. Paterson P.Y., Swanborg R.H. Demyelinating Diseases of the Central and Peripheral Nervous Systems. 1988;39-55 Little, Brown and Co. Boston.
31. Powell M.B., Mitchell D., Lederman J., Buckmeir J., Zamvil S.S., Graham M., Riddle N.H., Steinman L. Lymphotoxin and tumor necrosis factor-alpha production by myelin basic protein-specific T cell clones correlates with encephalitogenicity. Int. Immunol. 2:1990;539-544.
32. Reichlin S. Neuroendocrinology. Textbook of Endocrinology. 1992;121-155 Saunders, Philadelphia, PA.
33. Resko J.A., Malley A., Begley D., Hess D.L. Radioimmunoassay of testosterone during fetal development of the rhesus monkey. Endocrinology. 93:1973;156-161.
34. Rivier C., Rivest S. Effect of stress on the activity of the hypothalamic-pituitary-gonadal axis: peripheral and central mechanisms. Biol. Reprod. 45(4):1991;523-532.
35. Sakemura M., Takebe K., Nakagawa S. Inhibition of luteinizing hormone secretion induced by long term treatment with glucocorticoids in human subjects. J. Clin. Endocrinol. Metab. 44:1975;774-779.
36. Semple C.G., Gray C.E., Beastall G.H. Male hypogonadism: a non-specific consequence of illness. Q. J. Med. 64:1987;601-607.
37. Sharief M.K., Hedges R. Association between tumor necrosis factor and disease progression in patients with multiple sclerosis. New Engl. J. Med. 325:1991;467-472.
38. Spratt D.I. Altered gonadal steroidogenesis in critical illness: is treatment with anabolic steroids indicated? Best Pract. Res. Clin. Endocrinol. Metab. 154(4):2001;479-494.
39. Steinman L. Multiple sclerosis: a coordinated attack against myelin in the central nervous system. Cell. 85:1996;299-302.
40. Sullivan F., Hutchinson M., Bahandeka S., Moore R.E. Chronic hypothermia in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry. 50:1987;813-815.
41. Turnbull A.V., Rivier C. Cytokines within the neuroendocrine system. Curr. Opin. Endocrinol. Diabetes. 3:1996;149-156.
42. van Lambalgen R., Sanders E.A., D'Amato J. Sex distribution, age of onset and HLA profiles in two types of multiple sclerosis. A role for sex hormones and microbial infections in the development of autoimmunity. J. Neurol. Sci. 76:1986;13-21.
43. Vas C.J. Sexual impotence and some autonomic disturbances in men with MS. Acta Neurol. Scand. 45:1969;166-182.
44. Vinken P.J., Bruyn G.W. The neuropathology of multiple sclerosis. Handbook of Neurology. 1965;221-270 North Holland, Amsterdam.
45. Voskuhl R.R., Pitchekian-Halabi H., MacKenzie-Graham A., McFarland H.F., Raine C.S. Gender differences in autoimmune demyelination in the mouse: implications for multiple sclerosis. Ann. Neurol. 39:1996;724-733.
46. Whitacre C.C., Reingold S.C., O'Looney P.A. A gender gap in autoimmunity. Science. 283:1999;1277-1279.
47. Xiong Y., Hales D.B. The role of tumor necrosis factor-α in the regulation of mouse Leydig cell steroidogenesis. Endocrinology. 132(6):1993;2438-2444.
48. Zorzon M., Zivadinov R., Bosco A., Bragadin L.M., Moretti R., Bonfigli L., Morassi P., Iona L.G., Cazzato G. Sexual dysfunction in multiple sclerosis: a case-control study: I. Frequency and comparison of groups. Mult. Scler. 5(6):1999;418-427.